These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29115492)

  • 1. Epithelial‑mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3.
    You S; Guan Y; Li W
    Mol Med Rep; 2018 Jan; 17(1):1065-1070. PubMed ID: 29115492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
    Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
    Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of RNA interference (RNAi) lentiviral expression vector of DEK gene and its effect on the biological behavior of liver cancer cells].
    Li SH; Hou Y; Chen Z; Wu WR; Wu CX; Sun H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):868-875. PubMed ID: 33105933
    [No Abstract]   [Full Text] [Related]  

  • 4. The miR-1204 regulates apoptosis in NSCLC cells by targeting DEK.
    Qian Z; Yang J; Liu H; Yin Y; Hou L; Hu H
    Folia Histochem Cytobiol; 2019; 57(2):64-73. PubMed ID: 31246264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of STC2 gene silencing on colorectal cancer cells.
    Li Q; Zhou X; Fang Z; Pan Z
    Mol Med Rep; 2019 Aug; 20(2):977-984. PubMed ID: 31173256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of the DEK gene induces apoptosis and senescence in CaSki cervical carcinoma cells via the up-regulation of NF-κB p65.
    Liu K; Feng T; Liu J; Zhong M; Zhang S
    Biosci Rep; 2012 Jun; 32(3):323-32. PubMed ID: 22390170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.
    Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
    Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the DEK oncogene in the development of squamous cell carcinoma.
    Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
    Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of KLK12 inhibits viability and induces apoptosis in human colorectal cancer HT-29 cell line.
    Li Q; Zhou X; Fang Z; Zhou H
    Int J Mol Med; 2019 Nov; 44(5):1667-1676. PubMed ID: 31485623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of biological function on ovarian clear cell carcinoma ES2 cell line with ARID1A gene expression down-regulating in vitro].
    Lyu CS; Zhang YL; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):209-15. PubMed ID: 27030501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization.
    Nakashima T; Tomita H; Hirata A; Ishida K; Hisamatsu K; Hatano Y; Kanayama T; Niwa A; Noguchi K; Kato K; Miyazaki T; Tanaka T; Shibata T; Hara A
    Cancer Med; 2017 Oct; 6(10):2424-2439. PubMed ID: 28834425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
    Martinez-Useros J; Rodriguez-Remirez M; Borrero-Palacios A; Moreno I; Cebrian A; Gomez del Pulgar T; del Puerto-Nevado L; Vega-Bravo R; Puime-Otin A; Perez N; Zazo S; Senin C; Fernandez-Aceñero MJ; Soengas MS; Rojo F; Garcia-Foncillas J
    BMC Cancer; 2014 Dec; 14():965. PubMed ID: 25515240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOB1 is essential for the survival of RKO colorectal cancer cells.
    He XW; Feng T; Yin QL; Jian YW; Liu T
    World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
    Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
    World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
    Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
    Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.
    Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
    PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells.
    Yamazaki H; Iwano T; Otsuka S; Kagawa Y; Hoshino Y; Hosoya K; Okumura M; Takagi S
    Vet J; 2015 Apr; 204(1):60-5. PubMed ID: 25773167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
    Feng T; Liu Y; Li C; Li Z; Cai H
    Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.